Ignite Creation Date:
2024-05-05 @ 10:56 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01214083
Status:
COMPLETED
Last Update Posted:
2020-04-08
First Post:
2010-09-30
Brief Title:
N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence
Sponsor:
VA Office of Research and Development
Organization:
VA Office of Research and Development
Study Overview
Official Title:
N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence
Status:
COMPLETED
Status Verified Date:
2020-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether 1 the combination of N-acetylcysteine high-dose naltrexone 150 mg works better than high-dose naltrexone 150 mg alone in reducing alcohol drinking and 2 high-dose naltrexone 150 mg alone works better than low-dose naltrexone 50 mg alone in reducing alcohol drinking
Detailed Description:
The 3 groups N-acetylcysteine plus naltrexone 150 mg naltrexone 150 mg and naltrexone 50 mg will be compared in a 12-week randomized double-blind clinical trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None